Cargando…

Pancreatic involvement in patients with inborn errors of metabolism

BACKGROUND: Repeated inflammation of the pancreas can cause pancreatitis or diabetes. It is well recognized that the organic acidemias may be complicated by pancreatitis but less recognized are other metabolic disorders in which pancreatitis can occur. This study shows that long-term follow-up of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Woo Jin, Lim, Han Hyuk, Kim, Yoo-Mi, Chang, Mea Young, Kil, Hong Ryang, Kim, Jae Young, Song, Wung Joo, Levy, Harvey L., Kim, Sook-Za
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819202/
https://www.ncbi.nlm.nih.gov/pubmed/33472655
http://dx.doi.org/10.1186/s13023-021-01685-9
_version_ 1783638966409363456
author Hwang, Woo Jin
Lim, Han Hyuk
Kim, Yoo-Mi
Chang, Mea Young
Kil, Hong Ryang
Kim, Jae Young
Song, Wung Joo
Levy, Harvey L.
Kim, Sook-Za
author_facet Hwang, Woo Jin
Lim, Han Hyuk
Kim, Yoo-Mi
Chang, Mea Young
Kil, Hong Ryang
Kim, Jae Young
Song, Wung Joo
Levy, Harvey L.
Kim, Sook-Za
author_sort Hwang, Woo Jin
collection PubMed
description BACKGROUND: Repeated inflammation of the pancreas can cause pancreatitis or diabetes. It is well recognized that the organic acidemias may be complicated by pancreatitis but less recognized are other metabolic disorders in which pancreatitis can occur. This study shows that long-term follow-up of patients with various metabolic disorders in Korea revealed several with episodes of isolated pancreatitis or diabetes concomitantly with pancreatitis. RESULTS AND DISCUSSION: In this study, two patients with methylmalonic aciduria (MMA), two with propionic acidemia (PPA), one with fatty acid oxidation disorder (FAOD), and one with hyperornithinemia, gyrate atrophy, and juvenile onset diabetes mellitus (DM) were clinically followed for up to 10 – 21 years. Two Korean siblings with MMA showed recurrent pancreatitis from the age of 15 and 19, respectively. The frequency of admission due to pancreatitis was up to 11 times. One patient with MMA developed diabetes mellitus at the age of 20. The other patient with MMA developed recurrent pancreatitis at 4 years and diabetes at 8 years of age. One of the patients with PPA presented with diabetic ketoacidosis. The other PPA patient died of cardiac arrest at age 10. The patient with FAOD presented with pancreatitis at 10 years and died at the age of 15 years due to cardiac arrest. A 35-year-old woman with hyperornithinemia/gyrate atrophy was diagnosed with juvenile onset diabetes at the age of 7 years. No pancreatitis occurred during the follow-up period. CONCLUSIONS: We conclude that various metabolic disorders can trigger acute or chronic pancreatitis. Proper and prompt multidisciplinary management of metabolic derangement is crucial for preventing pancreatic damage. Further clinical and investigational studies are required to elucidate the pathogenesis of pancreatitis and diabetes mellitus in patients with inborn errors in metabolism.
format Online
Article
Text
id pubmed-7819202
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78192022021-01-22 Pancreatic involvement in patients with inborn errors of metabolism Hwang, Woo Jin Lim, Han Hyuk Kim, Yoo-Mi Chang, Mea Young Kil, Hong Ryang Kim, Jae Young Song, Wung Joo Levy, Harvey L. Kim, Sook-Za Orphanet J Rare Dis Review BACKGROUND: Repeated inflammation of the pancreas can cause pancreatitis or diabetes. It is well recognized that the organic acidemias may be complicated by pancreatitis but less recognized are other metabolic disorders in which pancreatitis can occur. This study shows that long-term follow-up of patients with various metabolic disorders in Korea revealed several with episodes of isolated pancreatitis or diabetes concomitantly with pancreatitis. RESULTS AND DISCUSSION: In this study, two patients with methylmalonic aciduria (MMA), two with propionic acidemia (PPA), one with fatty acid oxidation disorder (FAOD), and one with hyperornithinemia, gyrate atrophy, and juvenile onset diabetes mellitus (DM) were clinically followed for up to 10 – 21 years. Two Korean siblings with MMA showed recurrent pancreatitis from the age of 15 and 19, respectively. The frequency of admission due to pancreatitis was up to 11 times. One patient with MMA developed diabetes mellitus at the age of 20. The other patient with MMA developed recurrent pancreatitis at 4 years and diabetes at 8 years of age. One of the patients with PPA presented with diabetic ketoacidosis. The other PPA patient died of cardiac arrest at age 10. The patient with FAOD presented with pancreatitis at 10 years and died at the age of 15 years due to cardiac arrest. A 35-year-old woman with hyperornithinemia/gyrate atrophy was diagnosed with juvenile onset diabetes at the age of 7 years. No pancreatitis occurred during the follow-up period. CONCLUSIONS: We conclude that various metabolic disorders can trigger acute or chronic pancreatitis. Proper and prompt multidisciplinary management of metabolic derangement is crucial for preventing pancreatic damage. Further clinical and investigational studies are required to elucidate the pathogenesis of pancreatitis and diabetes mellitus in patients with inborn errors in metabolism. BioMed Central 2021-01-20 /pmc/articles/PMC7819202/ /pubmed/33472655 http://dx.doi.org/10.1186/s13023-021-01685-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Hwang, Woo Jin
Lim, Han Hyuk
Kim, Yoo-Mi
Chang, Mea Young
Kil, Hong Ryang
Kim, Jae Young
Song, Wung Joo
Levy, Harvey L.
Kim, Sook-Za
Pancreatic involvement in patients with inborn errors of metabolism
title Pancreatic involvement in patients with inborn errors of metabolism
title_full Pancreatic involvement in patients with inborn errors of metabolism
title_fullStr Pancreatic involvement in patients with inborn errors of metabolism
title_full_unstemmed Pancreatic involvement in patients with inborn errors of metabolism
title_short Pancreatic involvement in patients with inborn errors of metabolism
title_sort pancreatic involvement in patients with inborn errors of metabolism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819202/
https://www.ncbi.nlm.nih.gov/pubmed/33472655
http://dx.doi.org/10.1186/s13023-021-01685-9
work_keys_str_mv AT hwangwoojin pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT limhanhyuk pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT kimyoomi pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT changmeayoung pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT kilhongryang pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT kimjaeyoung pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT songwungjoo pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT levyharveyl pancreaticinvolvementinpatientswithinbornerrorsofmetabolism
AT kimsookza pancreaticinvolvementinpatientswithinbornerrorsofmetabolism